MNPRO deploys the first field-capable test for CWD, MN-QuIC.
MNPRO begins offering its own state-of-the-tech substrate for finding reliable results in RT-QuIC assays.
The Center expands to coordinate the multidisciplinary efforts of over 30 staff. MNPRO research now encompasses human protein diseases.